保持衰弱的人类心脏的代谢灵活性
William D Watson1,2, Peregrine G Green1,3, Andrew J M Lewis1
1Oxford Centre for Magnetic Resonance Research (W.D.W., P.G.G., A.J.M.L., P.A., L.V., S.N., O.J.R.), University of Oxford, UK.
Circulation
|May 18, 2023
概括
心力衰竭患者保持了新陈代谢的灵活性. 促进脂肪酸氧化, 而不是葡萄糖, 改善心脏的能量和功能,
科学领域:
- 心脏病学
- 代谢研究
- 生物化学
背景情况:
- 传统上认为心脏衰竭是代谢不灵活,缺乏氧气,导致能量不足和收缩能力受损.
- 目前针对新陈代谢调节剂增强葡萄糖氧化的疗法产生了不一致的结果.
研究的目的:
- 在心力衰竭患者中研究心脏代谢灵活性和氧气输送.
- 为了比较葡萄糖和脂肪酸代谢对心脏功能和能量的影响.
主要方法:
- 20名患有非缺血性心力衰竭的患者接受了胰岛素+葡萄糖 (I+G) 或Intralipid的输注.
- 使用心血管磁共振成像,-31磁共振光谱和侵入性动脉静脉采样.
- 评估了心脏功能,能量,基质利用和心肌氧吸收 (MVo2).
主要成果:
- 失败的心脏表现出显著的代谢灵活性,适应基板使用供应和工作量.
- 内脂输液增加了长链脂肪酸 (LCFA) 的吸收和氧化,改善了心肌能量和静脉/ 放脉功能.
- 尽管葡萄糖氧化增加,但胰岛素+葡萄糖输注并没有改善心脏功能.
结论:
- 在心力衰竭中,心脏代谢灵活性保持,排泄率降低.
- 增加LCFA吸收和氧化与心脏能量和收缩能力的改善有关.
- 促进脂肪酸氧化的策略可能为心力衰竭提供一种新的治疗方法.
相关概念视频
Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure II: Pathophysiology
17
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
17
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure I: Introduction
26
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
26
Pathophysiology of Cardiac Performance
714
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
714
Cardiomyopathy II: Dilated Cardiomyopathy
12
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12


